EU Restricts Red Yeast Rice Supplements Over Safety Concerns
Restrictions on daily doses and mandatory label warnings now apply to dietary supplements containing monacolins from red yeast rice sold in the EU following long-running safety concerns about the substance.
You may also be interested in...
Legal dispute between FDA and Pharmanex decided in 1999 could be precedent for using hemp-derived ingredients including CBD in supplements, even though CBD already has been authorized for clinical drug evaluation and for use in a drug, says attorney Miriam Guggenheim.
A round-up of the latest European executive appointments: CRN UK hires scientific advisor; EMA management board names vice chair; Boots UK appoints chief digital officer.
French natural consumer health specialist Havea looks set to be snapped up by private-equity firm BC Partners, which has set out a plan to step up the company's M&A and digitization activities.